


















Renal cell carcinoma (RCC) is the most common primary malig-
nant renal tumor. The classic triad of symptoms includes palpable 
abdominal mass, hematuria and flank pain. However, some of the 
patients diagnosed with RCC first present with paraneoplastic 
symptoms occurring as a consequence of secretion of various 
substances from the tumor. We present a case of a woman 
diagnosed with large kidney tumor, who developed acute heart 
failure soon after being treated with percutaneous embolization. 
We discuss toxic myocarditis as one of the possible causes for 
the acute hemodynamic compromise and the fatal outcome of 
the patient. Our case report highlights the complexity of this 
pathology and the importance of awareness of the various 
possible life-threatening complications.
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STRESZCZENIE
Rak nerkowo-komórkowy jest najczęstszym pierwotnym no-
wotworem złośliwym nerki. Klasyczna triada objawów z nim 
związanych obejmuje guz w jamie brzusznej, krwiomocz i ból 
w okolicy lędźwiowej. Jednak niektórzy pacjenci z rakiem ner-
kowo-komórkowym najpierw mają objawy paraneoplastyczne 
wywoływane przez substancje produkowane przez guz. W pracy 
przedstawiono przypadek kobiety, u której zdiagnozowano duży 
guz nerki i u której bezpośrednio po jego embolizacji rozwinęły 
się objawy ostrej niewydolności serca. Jako jedną z możliwych 
przyczyn ostrych zaburzeń hemodynamicznych i zgonu pacjenta 
rozważono toksyczne zapalenie mięśnia sercowego. Przedsta-
wiony opis przypadku podkreśla złożoność patologii, jak również 
potrzebę świadomości różnych możliwych zagrażających życiu 
powikłań związanych z jego leczeniem.
Słowa kluczowe: rak nerkowo-komórkowy, przezskórna embo-
lizacja, ostra niewydolność serca, toksyczne zapalenie mięśnia 
sercowego
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Introduction
Renal cell carcinoma (RCC) is the most common 
primary tumor of the kidney. Approximately 30% 
of patients with this neoplasm present with one 
of the following symptoms — hematuria, palpable 
abdominal mass and flank pain. However, in about 
20% the first presentation of the malignancy is para-
neoplastic symptom [1, 2]. The paraneoplastic syn-
drome consists of various systemic manifestations. 
It is a result of release of various tumor-associated 
humoral substances that are produced by the tu-
mor itself or by other tissues via immune-modula-
tion mechanisms [3]. Herein, we present a case of 
a 40-year-old female patient who developed acute 
heart failure after percutaneous embolization of 
kidney tumor and discuss the potential etiologies 







serca po embolizacji 
guza nerki. Opis 
przypadku
Niya Boykova Mileva1, 
Dobrin Iotkov Vassilev1, Robert J. Gil2, 
Gianluca Rigatelli3
1Cardiology Clinic, “Alexandrovska” University 
Hospital, Medical University, Sofia, Bulgaria
2Mossakowski Medical Research Centre, Polish 
Academy of Sciences, Warsaw, Poland Department 
of Invasive Cardiology, Central Clinical Hospital of the 
Ministry of the Interior, Warsaw, Poland
3Cardiovascular Diagnosis and Endoluminal 
Interventions, Adult Congenital Heart Interventions 























Figure 1. Renal angiography. A. Right renal artery before the embolization; B. Blood flow after embolization of right renal artery with 1000 mcm and 1500 


















A 40-year-old Caucasian female patient was referred 
to our department for percutaneous embolization 
of large kidney tumor. Computed tomography (CT) 
scan, performed two weeks before the admission, 
revealed large tumor originating from the right kidney 
with infiltration of the liver and inferior vena cava. 
Histology result from tru-cut biopsy was consistent 
with a clear cell renal cell carcinoma. On admission 
the patient’s vital signs included heart rate of 70 bpm, 
arterial blood pressure of 130/75 mmHg, body tem-
perature of 37.1°C, respiratory rate of 15 breaths per 
min. Her airway, lung, and heart examinations were 
unremarkable. The initial electrocardiogram showed 
normal sinus rhythm at 75 bpm; laboratory results 
were with no clinically significant abnormalities. 
Echocardiography before the intervention showed 
normal systolic function, ejection fraction (EF) of 
55%, and normal kinetics of the left ventricle with 
mild hypertrophy. 
On the second day after the admission the patient 
underwent selective embolization of the right re-
nal artery. We used 1000 mcm and 1500 mcm mi-
crospheres to achieve complete blood flow stasis 
(Figure 1). The procedure went uneventfully without 
any complications. After the intervention the woman 
complained of nausea, vomiting and abdominal pain, 
which was considered to be part of post-embolization 
syndrome. She was treated with opioid analgesics, 
antibiotics, crystalloid fluid infusions and stayed 
hemodinamically stable.
However, within the next 24 hours there was sud-
den deterioration of the patient’s condition. She 
complained of severe dyspnea and developed 
Figure 2. Coronary angiography revealing coronary vessels with no significant stenosis. A. Left anterior oblique view of the right coronary artery; B. Right 
anterior oblique view of the left anterior descending (LAD) and left circumflex (LCx) artery





















athe myocardial injury in our patient. The lysis of 
cancer cells after embolization leads to excessive 
release of intracellular proteins, nucleic acids, uric 
acid and electrolytes into the circulation [11]. What 
is more, it is possible that the renal cell carcinoma 
played a direct causative role via paraneoplastic 
systemic effects. It has been reported that clear 
cell renal carcinoma tumor cells secrete various 
proteins that serve as mediators for paraneoplastic 
symptoms — parathyroid hormone-related protein, 
erythropoietin, interleukin 6, vascular endothelial 
growth factor and others [12]. All these substances 
are associated with systemic manifestations such as 
cachexia, fever, polycythemia, and hypercalcemia 
and they may have been part of the pathogenesis 
of fulminant toxic myocarditis.
Conclusion
Nowadays, embolization of kidney tumors is a pro-
cedure performed preoperatively or a standard 
therapeutic option in patients contraindicated for 
surgery. However, interventions on kidney neopla-
sms can lead to various secondary complications. 
Such patients are challenging cases and their tre-
atment demand experience. We have described 
a rare case of a woman with acute heart failure due 
to fulminant toxic myocarditis in the context of an-
giographic embolization of a large clear cell renal 
cell tumor. Knowledge of this association accentu-
ates the importance of awareness of the different 
cardiovascular complications and the necessity of 
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pulmonary edema. Echocardiography revealed left 
ventricular systolic dysfunction with EF 20% and 
diffusely hypokinetic left ventricle. The laboratory 
results showed significant leukocytosis with white 
blood cell count of 52 G/l, increased creatinine, blood 
urea nitrogen and liver enzymes. However, there 
was adequate urine output (60 ml/h). The cardiac 
biomarkers also showed significant increase — cre-
atine phosphokinase (CPK) 4542 (reference range: 
20–180) U/L; MB fraction 143 (reference range < 
25) U/L; high sensitive Troponin T 0,522 (reference 
range: < 0.014) ng/ml.
Urgently, the patient was brought to the cathete-
rization lab and underwent invasive coronary an-
giography. The study did not reveal any significant 
coronary stenosis (Figure 2). Left ventricle angio-
graphy confirmed the severe left ventricular systolic 
dysfunction (Figure 3). For further evaluation of the 
patient’s pathology pulmonary artery angiography 
was performed. There was no evidence of pulmo-
nary hypertension or embolism. During the invasive 
procedure the patient decompensated with arterial 
blood pressure of 90/60 mmHg. Intra-aortic balloon 
pump was inserted in 1:2 mode. Soon afterwards 
the patient was intubated with subsequent mecha-
nical ventilation support. Despite the therapy with 
diuretics, antibiotics and catecholamine infusion, 
there was no improvement in patient’s condition and 
she died on the second day after the embolization.
Discussion
There are several cases reported of cardiovascular 
complications in patients who underwent percuta-
neous embolization of different types of tumors. 
Reports of rhythm and rate disturbances, as well 
as hypertensive crisis are described in the literature 
[4, 5]. Furthermore, there are several cases described 
of patients who developed acute heart failure soon 
after percutaneous embolization or ablation [6].
One of the probable mechanisms of the acute hemo-
dynamic compromise after such invasive procedure 
is stress-induced cardiomyopathy [7]. Also known 
as Takotsubo syndrome it occurs as a result of in-
creased sympathetic tone and excessive release of 
catecholamines — epinephrine, norepinephrine and 
dopamine. Women and especially middle aged are 
considered to be the most commonly affected [8]. 
This syndrome is associated with reversible systolic 
dysfunction, segmental contractile disturbance and 
electrocardiographic changes and it can develop in 
patients without any primary heart disease [9, 10].
Another possible cause for the acute hemodyna-
mic decompensation after tumor embolization is 
the development of fulminant toxic myocarditis as 
a consequence of the tumor lysis syndrome. We 
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Przezskórna embolizacja tętnicy nerkowej (PRAE, 
percutaneous renal artery embolisation) jest zabie-
giem wykonywanym od ponad 40 lat [1] obarczo-
nym niskim odsetkiem powikłań [2]. Trzeba jednak 
pamiętać, iż przy sporej atrakcyjności tego zabiegu 
dla chorego, niestety, nie ma dowodów potwierdza-
jących korzystny wpływ PRAE na rokowanie odległe 
u chorych z rakiem nerki.
Komentując każdy z opisywanych przez autorów 
przypadków klinicznych, należy pamiętać o kon-
tekście sytuacyjnym oraz możliwościach wykona-
nia badań, którym często daleko do rutynowych. 
Jednak ze względu na to, iż nierzadko specjalista 
endowaskularny staje przed podobnym wyzwaniem 
zdecydowano się podjąć komentarza.
Prezentowany przypadek dotyczy gwałtownie postę-
pującej niewydolności wielonarządowej najprawdo-
podobniej wtórnej do PRAE. Wysoka leukocytoza, 
na którą zwracają uwagę autorzy, to jeden z zespo-
łów paraneoplastycznych występujących u chorych 
na raka nerkowokomórkowego (RCC, renal cell 
carcinoma), wynikający ze zwiększonej produkcji 
cytokin, w tym GM-CSF (granulocyte-macrophage 
colony-stimulating factor). Interesująca byłaby zna-
jomość liczby eozynofilów u przedstawianej cho-
rej. Paraneoplastyczna hipereozynofilia jest zwykle 
łagodna i przebiega bezobjawowo, ale znane są 
opisy hipereozynofilii (> 25 tys./ul), przebiegają-
cej z uszkodzeniem narządowym (wieloogniskowe 
zatorowe uszkodzenie OUN, niewydolność serca 
z uogólnionymi zaburzeniami kurczliwości). Prawdo-
podobnie, zwiększona liczba eozynofilów jest wyni-
kiem działania cytokin lub odpowiedzią na nekrozę 
guza, co w przypadku omawianego przypadku jest 
mechanizmem bardziej prawdopodobnym. Podwyż-
szone wartości transaminaz, kinazy keratynowej, 
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